RAPP Operating Cash Flow (Statement)
Rapport Therapeutics Inc · Operating Cash Flow (Statement)
RAPP Operating Cash Flow (Statement)
Latest reported-$41.46Mperiod ending
RAPP Quarterly Cash from Operations (-$4.80M → -$41.46M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
RAPP operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -41,455,000 | |
| -13,061,000 | |
| -24,701,000 | |
| -17,465,000 | |
| -25,070,000 | |
| -20,237,000 | |
| -14,446,000 | |
| -16,415,000 | |
| -16,352,000 | |
| -17,615,000 | |
| -10,357,000 | |
| -5,424,000 | |
| -6,599,000 | |
| -4,801,000 |